Apollo Endosurgery ROA 2024

Apollo Endosurgery Aktienanalyse

What does Apollo Endosurgery do?

Apollo Endosurgery Inc is a medical technology company based in Austin, Texas that specializes in minimally invasive surgical technologies and products. It was founded in 2005 and has since become one of the leading providers of endoscopic instruments and systems. The business model of Apollo Endosurgery is based on the development and marketing of innovative products for minimally invasive surgery. The company focuses on three main areas: bariatric surgery, gastrointestinal surgery, and endoscopic surgery. The goal is to provide patients with minimally invasive solutions that are less invasive, safer, and more effective than traditional surgical methods. In the field of bariatric surgery, Apollo Endosurgery offers a wide range of products for the treatment of obese patients. This includes the bioabsorbable Orbera gastric balloon system, which provides a non-surgical alternative for weight reduction. It is introduced endoscopically into the stomach and can reduce the volume of the stomach, resulting in a faster feeling of satiety. The system needs to be removed after six months, but studies have shown that it can lead to significant weight loss. In the gastrointestinal surgery sector, Apollo Endosurgery offers the OverStitch system for endoscopic sutures. This system allows for the safe and easy performance of sutures in hard-to-reach areas of the GI tract without the need for open surgery. The system can be used for a variety of applications, including the treatment of fistulas and sealing leaks in the esophagus and intestine. Apollo Endosurgery's endoscopic surgery division focuses on the development of instruments and systems for endoscopic procedures. This includes the OverStitch system, as well as the Flex-Endoflex system for endoscopic procedures in the biliary system. These products enable safer and more effective procedures. Overall, Apollo Endosurgery has developed a wide range of products for minimally invasive surgery, offering doctors and patients a variety of treatment options. The company has also evolved through acquisitions, such as the acquisition of the biopolymer-based Orbera system by Apollo Endosurgery Inc. The company has a strong international presence, operating in Europe, Asia, and the USA, and has numerous partners in these regions. It has established close relationships with key clinics and physicians and is actively involved in researching and developing new technologies for minimally invasive surgery. In conclusion, Apollo Endosurgery Inc is a leading medical technology company focused on the development of innovative products for minimally invasive surgery. The company offers a wide range of products for bariatric, gastrointestinal, and endoscopic surgery and has strong relationships with key clinics and physicians. Apollo Endosurgery has a strong international presence and consistently works on researching and developing new technologies to provide minimally invasive solutions for patients worldwide. Apollo Endosurgery ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Apollo Endosurgery's Return on Assets (ROA)

Apollo Endosurgery's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Apollo Endosurgery's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Apollo Endosurgery's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Apollo Endosurgery’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Apollo Endosurgery stock

What is the Return on Assets (ROA) of Apollo Endosurgery this year?

The Return on Assets (ROA) of Apollo Endosurgery is -0.36 undefined this year.

What was the ROA of Apollo Endosurgery compared to the previous year?

The ROA of Apollo Endosurgery has increased by 92.59% compared to the previous year.

What consequences do high ROA have for investors of Apollo Endosurgery?

A high ROA is advantageous for investors of Apollo Endosurgery, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Apollo Endosurgery?

A low ROA can be unfavorable for investors of Apollo Endosurgery as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Apollo Endosurgery affect the company?

An increase in ROA of Apollo Endosurgery can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Apollo Endosurgery impact the company?

A reduction in the ROA of Apollo Endosurgery can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Apollo Endosurgery?

Some factors that can influence the ROA of Apollo Endosurgery include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Apollo Endosurgery important for investors?

The ROA of Apollo Endosurgery is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Apollo Endosurgery take to improve ROA?

To improve ROA, Apollo Endosurgery can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Apollo Endosurgery pay?

Over the past 12 months, Apollo Endosurgery paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Apollo Endosurgery is expected to pay a dividend of 0 USD.

What is the dividend yield of Apollo Endosurgery?

The current dividend yield of Apollo Endosurgery is .

When does Apollo Endosurgery pay dividends?

Apollo Endosurgery pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Apollo Endosurgery?

Apollo Endosurgery paid dividends every year for the past 0 years.

What is the dividend of Apollo Endosurgery?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Apollo Endosurgery located?

Apollo Endosurgery is assigned to the 'Health' sector.

Wann musste ich die Aktien von Apollo Endosurgery kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Apollo Endosurgery from 11/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.

When did Apollo Endosurgery pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Apollo Endosurgery in the year 2023?

In the year 2023, Apollo Endosurgery distributed 0 USD as dividends.

In which currency does Apollo Endosurgery pay out the dividend?

The dividends of Apollo Endosurgery are distributed in USD.